0001231919-24-000043.txt : 20240416
0001231919-24-000043.hdr.sgml : 20240416
20240416172159
ACCESSION NUMBER: 0001231919-24-000043
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240416
DATE AS OF CHANGE: 20240416
EFFECTIVENESS DATE: 20240416
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Outlook Therapeutics, Inc.
CENTRAL INDEX KEY: 0001649989
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 383982704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-510786
FILM NUMBER: 24848754
BUSINESS ADDRESS:
STREET 1: 485 ROUTE 1 SOUTH
STREET 2: BUILDING F, SUITE 320
CITY: ISELIN
STATE: NJ
ZIP: 08830
BUSINESS PHONE: 6096193990
MAIL ADDRESS:
STREET 1: 485 ROUTE 1 SOUTH
STREET 2: BUILDING F, SUITE 320
CITY: ISELIN
STATE: NJ
ZIP: 08830
FORMER COMPANY:
FORMER CONFORMED NAME: Oncobiologics, Inc.
DATE OF NAME CHANGE: 20150804
D
1
primary_doc.xml
X0708
D
LIVE
0001649989
Outlook Therapeutics, Inc.
485 ROUTE 1 SOUTH
BUILDING F, SUITE 320
ISELIN
NJ
NEW JERSEY
08830
6096193990
DELAWARE
Oncobiologics, Inc.
Corporation
true
Randy
H.
Thurman
c/o Outlook Therapeutics, Inc.
485 Route 1 South, Bldg. F, Suite 320
Iselin
NJ
NEW JERSEY
08830
Director
Yezan
Haddadin
c/o Outlook Therapeutics, Inc.
485 Route 1 South, Bldg. F, Suite 320
Iselin
NJ
NEW JERSEY
08830
Director
Kurt
J.
Hilzinger
c/o Outlook Therapeutics, Inc.
485 Route 1 South, Bldg. F, Suite 320
Iselin
NJ
NEW JERSEY
08830
Director
Lawrence
A.
Kenyon
c/o Outlook Therapeutics, Inc.
485 Route 1 South, Bldg. F, Suite 320
Iselin
NJ
NEW JERSEY
08830
Executive Officer
Director
Faisal
G.
Sukhtian
c/o Outlook Therapeutics, Inc.
485 Route 1 South, Bldg. F, Suite 320
Iselin
NJ
NEW JERSEY
08830
Director
Andong
Huang
c/o Outlook Therapeutics, Inc.
485 Route 1 South, Bldg. F, Suite 320
Iselin
NJ
NEW JERSEY
08830
Director
Gerd
Auffarth
c/o Outlook Therapeutics, Inc.
485 Route 1 South, Bldg. F, Suite 320
Iselin
NJ
NEW JERSEY
08830
Director
Julian
Gangolli
c/o Outlook Therapeutics, Inc.
485 Route 1 South, Bldg. F, Suite 320
Iselin
NJ
NEW JERSEY
08830
Director
Julia
A.
Haller
c/o Outlook Therapeutics, Inc.
485 Route 1 South, Bldg. F, Suite 320
Iselin
NJ
NEW JERSEY
08830
Director
C.
Russell
Trenary
c/o Outlook Therapeutics, Inc.
485 Route 1 South, Bldg. F, Suite 320
Iselin
NJ
NEW JERSEY
08830
Executive Officer
Director
Jeff
Evanson
c/o Outlook Therapeutics, Inc.
485 Route 1 South, Bldg. F, Suite 320
Iselin
NJ
NEW JERSEY
08830
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2024-04-15
false
true
true
true
false
0
13250005
5000002
8250003
The total offering amount above includes the amount, if any, that the Issuer could receive if all of the issued Warrants were exercised.
false
1
0
0
0
false
Outlook Therapeutics, Inc.
/s/ Lawrence Kenyon
Lawrence Kenyon
Chief Financial Officer, Treasurer and Secretary
2024-04-16